Voya Investment Management LLC Pacira Bio Sciences, Inc. Transaction History

Voya Investment Management LLC

$79.9 Billion
Q3 2024

A detailed history of Voya Investment Management LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 43,849 shares of PCRX stock, worth $830,500. This represents 0.0% of its overall portfolio holdings.

Number of Shares

43,849

Previous 36,887 18.87%

Holding current value

$830,500

Previous $1.06 Million 37.44%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$11.7 - $28.46 $81,455 - $198,138	6,962 Added 18.87%	43,849 $660,000
Q2 2024 Dec 03, 2024	SELL	$25.5 - $31.51 $177,531 - $219,372	-6,962 Reduced 15.88%	36,887 $1.06 Million
Q2 2024 Aug 14, 2024	SELL	$25.5 - $31.51 $2,754 - $3,403	-108 Reduced 0.29%	36,887 $1.06 Million
Q1 2024 Dec 06, 2024	SELL	$27.7 - $35.48 $189,855 - $243,179	-6,854 Reduced 15.63%	36,995 $1.08 Million
Q1 2024 May 15, 2024	BUY	$27.7 - $35.48 $86,396 - $110,662	3,119 Added 9.21%	36,995 $1.08 Million
Q4 2023 Feb 14, 2024	BUY	$26.32 - $34.31 $201,848 - $263,123	7,669 Added 29.26%	33,876 $1.14 Million
Q3 2023 Nov 14, 2023	BUY	$30.68 - $40.09 $6,013 - $7,857	196 Added 0.75%	26,207 $804,000
Q2 2023 Aug 14, 2023	BUY	$36.12 - $47.5 $25,753 - $33,867	713 Added 2.82%	26,011 $1.04 Million
Q1 2023 May 15, 2023	SELL	$35.53 - $43.38 $6.26 Million - $7.64 Million	-176,147 Reduced 87.44%	25,298 $1.03 Million
Q4 2022 Feb 14, 2023	SELL	$38.19 - $57.45 $4.42 Million - $6.64 Million	-115,661 Reduced 36.47%	201,445 $7.78 Million
Q3 2022 Mar 03, 2023	BUY	$51.24 - $58.89 $5.93 Million - $6.81 Million	115,661 Added 57.42%	317,106 $16.9 Million
Q3 2022 Nov 14, 2022	BUY	$51.24 - $58.89 $11.3 Million - $12.9 Million	219,747 Added 225.71%	317,106 $16.9 Million
Q2 2022 Aug 15, 2022	SELL	$51.49 - $81.64 $12.1 Million - $19.2 Million	-235,409 Reduced 70.74%	97,359 $5.68 Million
Q1 2022 May 16, 2022	BUY	$60.03 - $76.49 $18.3 Million - $23.3 Million	304,266 Added 1067.53%	332,768 $25.4 Million
Q4 2021 Feb 14, 2022	SELL	$47.97 - $62.21 $100,017 - $129,707	-2,085 Reduced 6.82%	28,502 $1.72 Million
Q3 2021 Nov 15, 2021	SELL	$54.64 - $61.3 $1,256 - $1,409	-23 Reduced 0.08%	30,587 $1.71 Million
Q2 2021 Aug 16, 2021	SELL	$59.18 - $69.99 $94,924 - $112,263	-1,604 Reduced 4.98%	30,610 $1.86 Million
Q1 2021 May 17, 2021	BUY	$59.31 - $78.82 $28,765 - $38,227	485 Added 1.53%	32,214 $2.26 Million
Q4 2020 Feb 16, 2021	BUY	$50.47 - $66.26 $361,768 - $474,951	7,168 Added 29.18%	31,729 $1.9 Million
Q3 2020 Nov 16, 2020	SELL	$51.97 - $63.0 $10,913 - $13,230	-210 Reduced 0.85%	24,561 $1.48 Million
Q2 2020 Aug 14, 2020	SELL	$30.8 - $52.47 $183,075 - $311,881	-5,944 Reduced 19.35%	24,771 $1.3 Million
Q1 2020 May 15, 2020	BUY	$28.4 - $50.7 $312,400 - $557,700	11,000 Added 55.8%	30,715 $1.03 Million
Q4 2019 Feb 14, 2020	BUY	$36.31 - $46.83 $130,352 - $168,119	3,590 Added 22.26%	19,715 $893,000
Q2 2019 Aug 14, 2019	SELL	$36.57 - $47.97 $7,972 - $10,457	-218 Reduced 1.33%	16,125 $701,000
Q1 2019 May 15, 2019	SELL	$36.47 - $42.17 $13,384 - $15,476	-367 Reduced 2.2%	16,343 $622,000
Q4 2018 Feb 14, 2019	BUY	$41.31 - $52.16 $21,481 - $27,123	520 Added 3.21%	16,710 $719,000
Q3 2018 Nov 14, 2018	SELL	$32.85 - $52.0 $5,748 - $9,100	-175 Reduced 1.07%	16,190 $796,000
Q2 2018 Aug 14, 2018	SELL	$27.5 - $39.8 $32,725 - $47,362	-1,190 Reduced 6.78%	16,365 $524,000
Q1 2018 May 15, 2018	SELL	$29.98 - $46.35 $17.1 Million - $26.5 Million	-570,892 Reduced 97.02%	17,555 $547,000
Q4 2017 Feb 14, 2018	SELL	$31.85 - $46.95 $81,153 - $119,628	-2,548 Reduced 0.43%	588,447 $26.9 Million
Q3 2017 Nov 14, 2017	BUY	$35.7 - $39.5 $21.1 Million - $23.3 Million	590,995	590,995 $22.2 Million

Others Institutions Holding PCRX

# of Institutions

263

Shares Held

50.4M

Call Options Held

429K

Put Options Held

391K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $868M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Account

Voya Investment Management LLC Pacira Bio Sciences, Inc. Transaction History